Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction
Current Treatment Options in Cardiovascular Medicine · 2024-06 · 26 (6) · 139-160
DOI: 10.1007/s11936-024-01038-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Treatment Options in Cardiovascular Medicine, online erschienen am 20.05.2024. Verfasst von Nandan Kodur und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, US. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Purpose of review The purpose of this review is to discuss myocardial recovery in heart failure with reduced ejection fraction (HFrEF) and to summarize the contemporary insights regarding heart failure with improved ejection fraction (HFimpEF). Recent findings Improvement in left ventricular ejection fraction (LVEF ≥ 40%) with improved prognosis can be achieved in one out of three (10–40%) patients with HFrEF treated with guideline-directed medical therapy. Clinical predictors include non-ischemic etiology of HFrEF, less abnormal blood or imaging biomarkers, and lack of specific pathogenic genetic variants. However, a subset of patients may ultimately relapse, suggesting that many patients are merely in remission rather than having fully recovered. Summary Patients with HFimpEF have improved prognosis but nonetheless remain at risk of relapse and long-term adverse events. Future studies will hopefully chart the natural history of HFimpEF and identify clinical predictors such as blood or novel imaging biomarkers that distinguish subgroups of patients based on differential trajectory and prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, US.
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, US.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Kodur, N., & Tang, W. H. W. (2024). Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction. Current Treatment Options in Cardiovascular Medicine, 26(6), 139-160. https://doi.org/10.1007/s11936-024-01038-2
Vancouver
Kodur N, Tang WHW. Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction. Current Treatment Options in Cardiovascular Medicine. 2024;26(6):139-160. doi:10.1007/s11936-024-01038-2
BibTeX
@article{Kodur2024,
author = {Kodur, Nandan and Tang, W H Wilson},
title = {Myocardial Recovery and Relapse in Heart Failure With Improved Ejection Fraction},
journal = {Current Treatment Options in Cardiovascular Medicine},
year = {2024},
volume = {26},
number = {6},
pages = {139--160},
doi = {10.1007/s11936-024-01038-2}
}
EUVIMED